Back to Selection     Print       Date : 30 Jun 2026
Fund Summary
ICICI Pru Pharma Healthcare And Diagnostics Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 13-Jul-18
Corpus(Cr.) 6625.0 Latest NAV 43.76 As on 29-07-2026
Equity(%) 96.05 52 Week High 43.89
Debt(%) 3.95 52 Week Low 36.38
Others(%) 0.0 Exit Load 1% for redemption within 15 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.55
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Dharmesh Kakkad
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 39.74%
Top 10 Holdings 60.16%
Top 25 Holdings 89.64%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 75.77
Healthcare 12.27
Retail 5.35
Cash 3.95
Chemicals 1.33
Miscellaneous 1.33
 
 
 
 
 
Portfolio Metrics
PB Ratio 4.45
PE Ratio 38.36
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 12.20
Dr Reddys Laboratories Limited 8.22
Mankind Pharma Limited 6.98
Cipla Limited 6.67
Alkem Laboratories Limited 5.67
DIVI LABORATORIES LTD 5.57
Cohance Lifesciences Limited 4.31
TREPS 3.78
MedPlus Health Services Limited 3.66
Max Healthcare Institute Limited 3.10
Syngene International Limited 2.89
Biocon Limited 2.59
ALEMBIC PHARMACEUTICALS 2.58
Abbott India Limited 2.47
Lupin Limited 2.30
Thyrocare Technologies Limited 2.24
Akums Drugs & Pharmaceuticals Ltd. 2.05
Pfizer Limited 1.86
Entero Healthcare Solutions 1.69
J B Chemicals and Pharma Ltd 1.56
Alivus Life Sciences 1.54
Blue Jet Healthcare Limited 1.51
Rainbow Childrens Medicare Limited 1.44
Metropolis Healthcare Limited 1.42
Hikal Limited 1.34

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
2.43% 9.92% 17.92% 5.70%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.46% 0.94% -3.91% -1.20%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
3.81% 12.06% 21.63% 11.52%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
11.18% 23.17% 16.33% 0.00%
 
 
0.01% 8.55% 10.25% 12.21%
 
 
10.97% 20.91% 14.75% 10.84%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
ICICI Pru Pharma Healthcare And Diagnostics Fund (G) 16.44% 1.1997 11.2610% 42.8765 0.1559
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
ICICI Pru Pharma Healthcare And Diagnostics Fund (G) 17.8695% 0.0003 0.3113 14.2323 1.4791
 
Back to Selection